Cardioprotective Effects Of Genetically Engineered Cardiac Stem Cells By Spheroid Formation On Ischemic Cardiomyocytes

被引：0
|
作者：
Jeong, Han Saem
Kim, Jong-ho
Hong, Soon Jun
机构：
来源：
CIRCULATION RESEARCH | 2022年 / 131卷
关键词：
Cardioprotection; Acute coronary syndromes; Cellular Engineering;
D O I：
10.1161/res.131.suppl_1.P1027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1027
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells
    Wei, Feng
    Wang, Tingzhong
    Liu, Juanjuan
    Du, Yuan
    Ma, Aiqun
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (18) : 2661 - 2670
  • [42] Ischemic preconditioning mobilizes cardiac stem cells into the ischemic/reperfused myocardium
    Dawn, B
    Hunt, G
    Guo, Y
    Stein, AB
    Rezazadeh, A
    Wu, WJ
    Tan, W
    Bolli, R
    CIRCULATION, 2004, 110 (17) : 138 - 138
  • [43] Enhancement of bone formation by genetically engineered human umbilical cord-derived mesenchymal stem cells expressing osterix
    Wang, Bin
    Huang, Shengyun
    Pan, Lina
    Jia, Shanshan
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 116 (04): : E221 - E229
  • [44] Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
    Feric, Nicole T.
    Radisic, Milica
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 96 : 110 - 134
  • [45] Engineered Cardiac Tissues Utilizing Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Wendel, J. S.
    Tranquillo, R. T.
    TISSUE ENGINEERING PART A, 2014, 20 : S31 - S32
  • [46] Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington's Disease
    Olson, Scott D.
    Pollock, Kari
    Kambal, Amal
    Cary, Whitney
    Mitchell, Gaela-Marie
    Tempkin, Jeremy
    Stewart, Heather
    McGee, Jeannine
    Bauer, Gerhard
    Kim, Hyun Sook
    Tempkin, Teresa
    Wheelock, Vicki
    Annett, Geralyn
    Dunbar, Gary
    Nolta, Jan A.
    MOLECULAR NEUROBIOLOGY, 2012, 45 (01) : 87 - 98
  • [47] Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease
    Scott D. Olson
    Kari Pollock
    Amal Kambal
    Whitney Cary
    Gaela-Marie Mitchell
    Jeremy Tempkin
    Heather Stewart
    Jeannine McGee
    Gerhard Bauer
    Hyun Sook Kim
    Teresa Tempkin
    Vicki Wheelock
    Geralyn Annett
    Gary Dunbar
    Jan A. Nolta
    Molecular Neurobiology, 2012, 45 : 87 - 98
  • [48] Automated sorting of genetically engineered embryonic stem cells for generation of mouse models
    Gunther Kauselmann
    Heidrun Kern
    Anne Klein-Vehne
    Torsten Müller
    Annette Pfennig
    Branko Zevnik
    Nature Methods, 2007, 4 (1) : v - vi
  • [49] Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
    K Nakamura
    Y Ito
    Y Kawano
    K Kurozumi
    M Kobune
    H Tsuda
    A Bizen
    O Honmou
    Y Niitsu
    H Hamada
    Gene Therapy, 2004, 11 : 1155 - 1164
  • [50] Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington disease.
    Pollock, K.
    Stewart, H.
    Nelson, H.
    Fink, K. D.
    Cary, W.
    Hendrix, K.
    Torrest, A.
    Deng, P.
    Gutierrez, J.
    Nacey, C.
    Pepper, K.
    Gruenloh, W.
    Bauer, G.
    Annett, G.
    Tempkin, T.
    Wheelock, V.
    Nolta, J. A.
    NEUROTHERAPEUTICS, 2016, 13 (01) : 240 - 240
12345